In addition, CQ or BECN1-knockdown increased phosphorylation of eEF2 specifically under treatment of TGF-β1 not only in A549 but also in other types of cancer cells although this eEF2 phosphorylation at T56 varied among these cancer cells (Figure 4). The gene discussed is TGFB1; the disease is cancer.